Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Riverstone HoldingsSGX:AP4 +1.81%67 Return-on-Tangible-Asset is 13.26% as of Dec. 2025, which is 17% below its 10-year median of 16.03. GuruFocus rates SGX:AP4 with a GF Score™ of 67/100 and a GF Value™ of S$0.78 (Fairly Valued). The stock has 5 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Riverstone Holdings ranks better than 87.25% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Riverstone Holdings's annualizedNet Income for the quarter that ended in Dec. 2025 was S$68.1 Mil. Riverstone Holdings's average total tangible assets for the quarter that ended in Dec. 2025 was S$514.0 Mil. Therefore, Riverstone Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2025 was 13.26%.
The historical rank and industry rank for Riverstone Holdings's Return-on-Tangible-Asset or its related term are showing as below:
SGX:AP4'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 11.05 Med: 16.03 Max: 64.26
Current: 12.21
During the past 13 years, Riverstone Holdings's highest Return-on-Tangible-Asset was 64.26%. The lowest was 11.05%. And the median was 16.03%.
SGX:AP4's Return-on-Tangible-Asset is ranked better than 87.25% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 0.74
vs SGX:AP4: 12.21
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Riverstone Holdings Return-on-Tangible-Asset Related Terms
Riverstone Holdings Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Riverstone Holdings's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:AP4 vs ISRG, BDX, MDLN: Return-on-Tangible-Asset Comparison
For the Medical Instruments & Supplies subindustry, Riverstone Holdings's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Riverstone Holdings Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Riverstone Holdings's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Riverstone Holdings's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of 13.26% mean?
Riverstone Holdings (SGX:AP4) has a Return-on-Tangible-Asset of 13.26% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Riverstone Holdings and its competitors. This is 17% below median its historical median of 16.03. Over the past decade, Riverstone Holdings' Return-on-Tangible-Asset has ranged from 11.05 to 64.26. According to the industry distribution chart, Riverstone Holdings ranks #109 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 12.7%.
Is Riverstone Holdings' Return-on-Tangible-Asset too high?
Riverstone Holdings' current Return-on-Tangible-Asset of 13.26% is 17% below median its 10-year median of 16.03. Over the past 10 years, this metric has ranged from a low of 11.05 to a high of 64.26. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.74. Riverstone Holdings' value of 13.26% is 1691.9% above this industry median. Based on the distribution chart, Riverstone Holdings ranks #109 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Riverstone Holdings has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Riverstone Holdings' Return-on-Tangible-Asset compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Riverstone Holdings ranks #109 out of 855 companies for Return-on-Tangible-Asset. This places Riverstone Holdings in the top 13% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 0.74. Riverstone Holdings' value of 13.26% is 1691.9% above this benchmark. Historically, Riverstone Holdings' own Return-on-Tangible-Asset has ranged from 11.05 to 64.26 over the past decade. While the company's 10-year median is 16.03 vs. the industry median of 0.74, Riverstone Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.74, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Riverstone Holdings's current Return-on-Tangible-Asset of 13.26% is 1691.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Riverstone Holdings and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Riverstone Holdings's current Return-on-Tangible-Asset is 13.26%, which is 17% below median its own 10-year median of 16.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Riverstone Holdings stock overvalued right now?
Based on GuruFocus' analysis, Riverstone Holdings (SGX:AP4) is currently considered Fairly Valued. The stock's GF Value™ is S$0.78, compared to a current price of S$0.85 — trading 8.3% above its estimated fair value. The current Return-on-Tangible-Asset is 13.26%, which is 17% below median its 10-year median of 16.03 and 1691.9% above the Medical Devices & Instruments industry median of 0.74. Riverstone Holdings' overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Riverstone Holdings (SGX:AP4), the current Return-on-Tangible-Asset is 13.26% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Riverstone Holdings (SGX:AP4) Overvalued in 2026?
Based on GuruFocus' analysis, Riverstone Holdings stock appears to be overvalued.
The current stock price of S$0.85 is trading 8.3% above its estimated GF Value™ of S$0.78.
GuruFocus considers Riverstone Holdings to be Fairly Valued.
Key valuation signals for SGX:AP4:
Return-on-Tangible-Asset: 13.26% (17% below median its 10-year median of 16.03)
GF Value™: S$0.78 vs. price of S$0.85 (8.3% above fair value)
Industry Position: 1691.9% above the Medical Devices & Instruments median (#109 of 855)
No single metric tells the full story. See the SGX:AP4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Riverstone Holdings Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the manufacture and sales of gloves and non-glove consumables such as finger cots, static shielding bags, face masks, wipers, and packaging materials. The group's products are widely qualified and used in the Hard Disk Drive, and semiconductor industries. It operates in three segments based on its geography: Malaysia, Thailand, China, Singapore, and Others, of which the majority of its revenue comes from Malaysia.
67GF Score
Get the complete analysis for SGX:AP4
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:AP4 has been successfully added to your 
